Results 171 to 180 of about 337,050 (372)

Bilateral synchronous renal cell carcinoma: a case report [PDF]

, 1995
55歳男.人間ドックで偶然みつかった両側同時性腎細胞癌(両側ともTl)に対し, 右腎摘出術及び左腎部分切除術を施行した例A case of bilateral synchronous renal cell carcinoma is reported. The patient was a 55-year-old man.
中村, 靖夫, 伊藤, 秀明, 大川, 光央, 徳永, 周二, 松井, 晃   +4 more
core  

VHL Tumor Suppressor Gene Alterations Associated With Good Prognosis in Sporadic Clear-Cell Renal Carcinoma [PDF]

, 2002
Yao Masahiro
openalex   +1 more source

Engineered Plasmonic and Fluorescent Nanomaterials for Biosensing, Motion, Imaging, and Therapeutic Applications

Advanced Materials, EarlyView.
A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto, Juan C. Fraire, Daniel Sánchez‐deAlcázar, Samuel Sánchez   +3 more
wiley   +1 more source

Bladder Metastasis from Clear Cell Renal Cell Carcinoma: A Case Report

Caucasian Medical Journal
Kidney cancer is one of the most common urologic cancers. Generally, kidney cancer metastases occur in the liver, lungs, and bones, but we can see rare metastases such as those in the urinary bladder.
İlkin Hamid-Zada, Mammad Khalilov, Özgür Efiloğlu, Asıf Yıldırım   +3 more
doaj   +1 more source

RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma

Molecular Therapy: Nucleic Acids, 2022
MEX3A is an RNA-binding protein that mediates mRNA decay through binding to 3′ untranslated regions. However, its role and mechanism in clear cell renal cell carcinoma remain unknown.
Yuntan Qiu, Meng Meng, Chuanzhen Cao, Jingyuan Zhang, Xu Cheng, Yongxin Huang, Haotian Cao, Yun Li, Duanqing Tian, Yongsheng Huang, Li Peng, Kaishun Hu, Yin Zhang, Jianyou Liao, Jiehua He, Xiaochun Wang, Daning Lu, Lehang Lin, Xingang Bi, Dong Yin   +19 more
doaj  

1766: A Protocol for Extended Lymph Node Dissection Using Primary Tumor Pathologic Features for Patients Treated with Radical Nephrectomy for Clear Cell Renal Cell Carcinoma [PDF]

, 2004
Michael L. Blute, Bradley C. Leibovich, John C. Cheville, Christine M. Lohse, Horst Zincke   +4 more
openalex   +1 more source

Understanding miR‐200c: an Important Player in Resistance to Cancer Treatment

Advanced Therapeutics, EarlyView.
How can one microRNA alter cancer's response to therapy? miR‐200c plays a central role in therapeutic resistance by modulating epithelial‐mesenchymal transition, apoptosis, cancer stemness features, and drug efflux. This review outlines the context‐dependent functions of miR‐200c in various cancers and highlights its potential as both a biomarker and a
Fatma Sanli, Omer Faruk Karatas
wiley   +1 more source

Clear cell renal cell carcinoma

Radiopaedia.org, 2014
A. Haouimi, Bruno Paulino Di Muzio
semanticscholar   +2 more sources

The L1 Cell Adhesion Molecule Is Induced in Renal Cancer Cells and Correlates with Metastasis in Clear Cell Carcinomas [PDF]

, 2005
Yves Allory, Yasuko Matsuoka, Céline Bazille, Erik Christensen, Pierre Ronco, Hanna Dębiec   +5 more
openalex   +1 more source

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47

Advanced Science, EarlyView.
Cancer cell‐intrinsic SMYD3 orchestrates an immunosuppressive microenvironment and impairs the response to PD‐1 blockade by reprogramming immune cells landscape in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). The immunomodulatory function of SMYD3 is mediated via the SREBP1/CD47 pathway.
Zhengfang Liu, Xiumei Zhao, Maolin Zang, Huiyang Yuan, Xin Qin, Xiaofeng Li, Shuo Zhao, Ruirong Tan, Keqiang Yan, Li Liu, Yidong Fan, Ning Zhang, Benkang Shi, Bo Han, Shouzhen Chen   +14 more
wiley   +1 more source